---
title: "諾和諾德首席執行官：我們將按需繼續招聘，但在招聘時會更加謹慎。"
description: "諾和諾德首席執行官：我們將按需繼續招聘，但在招聘時會更加謹慎。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/256717611.md"
published_at: "2025-09-10T10:17:11.000Z"
---

# 諾和諾德首席執行官：我們將按需繼續招聘，但在招聘時會更加謹慎。

諾和諾德首席執行官：我們將按需繼續招聘，但在招聘時會更加謹慎。

### Related Stocks

- [NVO.US - 諾和諾德公司](https://longbridge.com/zh-HK/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/zh-HK/news/275652909.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/zh-HK/news/275761183.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/zh-HK/news/275789396.md) |
| Oppenheimer Asset Management Inc. Has $31.35 Million Stock Position in Novo Nordisk A/S $NVO | Oppenheimer Asset Management Inc. increased its stake in Novo Nordisk A/S by 14.4% in Q3, holding 565,007 shares valued  | [Link](https://longbridge.com/zh-HK/news/275287765.md) |
| Novo Nordisk Aims To Start Selling Its Weight-Loss Blockbuster Wegovy In Vials - Bloomberg News | NOVO NORDISK AIMS TO START SELLING ITS WEIGHT-LOSS BLOCKBUSTER WEGOVY IN VIALS - BLOOMBERG NEWS | [Link](https://longbridge.com/zh-HK/news/275654518.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。